Conventional cancer therapy: promise broken or promise delayed?
- 1 May 1998
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 351, SII9-SII16
- https://doi.org/10.1016/s0140-6736(98)90327-0
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Special Communication from the National Cancer Institute: Survival After Breast-Sparing Surgery Versus MastectomyJNCI Journal of the National Cancer Institute, 1994
- Evidence-Based Recommendations Against Neoadjuvant Chemotherapy for Routine Management of Patients with Squamous Cell Head and Neck CancerCancer Investigation, 1994
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991
- Distribution and Activity of Antineoplastic Drugs in a Tumor ModelJNCI Journal of the National Cancer Institute, 1989
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978